益欣康泰治疗慢性前列腺炎前、后前列腺液超氧化物歧化酶测定及临床意义  

Clinical Significance of SOD Levels in Saccus Prostaticus of Patient With Chronic Prostatitis Before and After Oral Yixinkangtai

作　　者：钟惟德[1] 蔡岳斌[1] 胡建波[1] 王良圣[1] 魏鸿蔼[1] 余安迪[1] 

机构地区：[1]广州市第一人民医院泌尿外科,广州市510180

出　　处：《中国药房》2002年第2期99-100,共2页China Pharmacy

基　　金：广东省科委重点攻关课题 (1998110)

摘　　要：目的 :探讨口服益欣康泰治疗慢性前列腺炎的疗效。方法 :通过对85例慢性前列腺炎患者口服益欣康泰治疗前、后前列腺液超氧化物歧化酶 (SOD )含量测定,结合临床主观症状与客观指标的观察,总结其疗效。结果 :慢性前列腺炎患者前列腺液SOD含量为 (153 76±90 23)mg/L,较健康男性 (220.31±85.02)mg/L为低 (P<0.01) ,经2个月口服益欣康泰提高为 (232.35±82.56)mg/L ,而主观症状改善有效率为53 % ,客观指标改善有效率为55 %。结论 :给予该药能提高前列腺液SOD含量 。OBJECTIVE:To evaluate the therapeutic effect of oral Yixinkangtai(YXKT) on chronic prostatitis METHODS:85 patients with chronic prostatitis were observed for the levels of SOD in saccus prostaticus as well as their subjective symptoms and objective indices before and after taking YXKT to evaluate the therapeutic effect RESULTS:The average level of SOD in saccus prostaticus in patients with chronic prostatitis was (153 76±90 23)mg/L,which was lower than(220 31±85 02)mg/L as in normal males(P<0 01),and was elevated to (232 35±82 56)mg/L after a 2-month therapy with YXKT The effective rate was 53% for relief of subjective symptoms and 55% for relief of objective indices CONCLUSION:This therapy can elevate the level of SOD in saccus prostaticus and may be considered effective for treating chronic prostatitis

关 键 词：益欣康泰 慢性前列腺炎 超氧化物歧化酶 治疗 

分 类 号：R697.330.5[医药卫生—泌尿科学]